Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Amgen Inc. (AMGN) Q1 2023 Earnings Call Transcript
09:28pm, Thursday, 27'th Apr 2023
Amgen Inc. (AMGN) Q1 2023 Earnings Call Transcript.
Amgen (AMGN) Q1 Earnings Beat Estimates
07:01pm, Thursday, 27'th Apr 2023
Amgen (AMGN) came out with quarterly earnings of $3.98 per share, beating the Zacks Consensus Estimate of $3.84 per share. This compares to earnings of $4.25 per share a year ago.
Final Trades: MO, GOOGL, MCD & AMGN
06:59pm, Tuesday, 25'th Apr 2023
The final trades of the day with CNBC's Melissa Lee and the Fast Money traders.
Can Amgen (AMGN) Keep the Earnings Streak Alive in Q1?
12:12pm, Monday, 24'th Apr 2023
Volume growth from Amgen's (AMGN) key drugs like Prolia, Repatha and Evenity, among others is expected to have been partially offset by biosimilar/generic competition for mature drugs.
4 Pharma, Biotech Stocks Poised to Beat Q1 Earnings Estimates
09:53am, Monday, 24'th Apr 2023
We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.
AMGEN ANNOUNCES WEBCAST OF 2023 FIRST QUARTER FINANCIAL RESULTS
04:00pm, Friday, 21'st Apr 2023
THOUSAND OAKS, Calif. , April 21, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced that it will report its first quarter financial results on Thursday, April 27, 2023, after the close of the U
Amgen (AMGN) Wins Patent Appeal for Blockbuster Psoriasis Drug
09:56am, Thursday, 20'th Apr 2023
The Appeal Court's decision upholding the patents for Amgen's (AMGN) blockbuster psoriasis drug Otezla will prevent drug-makers from selling a generic version till February 2028.
7 Dividend Stocks to Buy That Are Backed by Strong Cash Flows
02:52pm, Sunday, 16'th Apr 2023
Many investors have heard the phrase “cash is king” relative to the current banking crisis. But it also has significance for dividend investors.
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
DivHut Portfolio Update: March 2023
12:11am, Wednesday, 12'th Apr 2023
The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book. Earning $1,893.81 represents 12.6% year o
Diving Into the Smead Value Fund's Top Holdings as Value Conference Approaches
04:29pm, Monday, 10'th Apr 2023
With the goal of generating long-term capital appreciation, the Smead Value Fund (Trades, Portfolio) is known for investing in a concentrated number of stocks that have strong competitive advantages.
Love Dividends? These 3 Stocks Are Smart Buys Right Now
05:27am, Sunday, 09'th Apr 2023
CVS Health is famous for its pharmacies, but it's the non-retail aspect of its business that makes it a great dividend stock to buy now. Amgen's biotechnology operation could get a lot bigger with the
Nicholas Ward's Dividend Growth Portfolio: Special Fixed Income Edition
12:56am, Friday, 07'th Apr 2023
I'm reviewing my February and March results in this piece. My passive income stream grew by 22.63% in February and by 46.87% in March.
Income Investors: These 2 Stocks Have Quadrupled Their Dividend Payouts Over the Past 10 Years
05:44am, Thursday, 06'th Apr 2023
Amgen and LeMaitre Vascular both possess solid product portfolios and pipelines to drive future earnings growth. Their payouts are well-covered by their earnings.
Final Trades: Amgen, Manhattan Assoc., HYG & TLT
06:48pm, Wednesday, 05'th Apr 2023
The final trades of the day. With CNBC's Melissa Lee and the Fast Money traders.
